Free Trial

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (FBT) Competitors

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation logo
GBX 1,619.50 -17.30 (-1.06%)
As of 09/24/2025

FBT vs. PRSM, KAPE, KNOS, TRST, LTG, ALFA, GBG, IMO, NCC, and CER

Should you be buying First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation stock or one of its competitors? The main competitors of First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation include Blue Prism Group (PRSM), Kape Technologies (KAPE), Kainos Group (KNOS), Trustpilot Group (TRST), Learning Technologies Group (LTG), Alfa Financial Software (ALFA), GB Group (GBG), IMImobile (IMO), NCC Group (NCC), and Cerillion (CER). These companies are all part of the "software - application" industry.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation vs. Its Competitors

Blue Prism Group (LON:PRSM) and First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation (LON:FBT) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation is trading at a lower price-to-earnings ratio than Blue Prism Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Blue Prism Group£167.30M0.00N/A-£53.80N/A
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationN/AN/AN/A-£1.10-1,472.27

In the previous week, Blue Prism Group's average media sentiment score of 0.00 equaled First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation'saverage media sentiment score.

Company Net Margins Return on Equity Return on Assets
Blue Prism GroupN/A N/A N/A
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation N/A N/A N/A

Summary

Blue Prism Group beats First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation on 2 of the 3 factors compared between the two stocks.

Get First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FBT vs. The Competition

MetricFirst Trust NYSE Arca Biotechnology UCITS ETF Class A USD AccumulationSoftware IndustryComputer SectorLON Exchange
Market Cap£664.34M£7.14B£31.89B£2.57B
Dividend YieldN/A3.75%3.14%5.33%
P/E Ratio-1,472.271,262.65454.405,410.48
Price / SalesN/A255.441,722.7698,350.38
Price / Cash3.5417.2938.0627.92
Price / BookN/A10.847.268.60
Net IncomeN/A£49.83M£809.16M£5.89B
7 Day Performance1.92%-0.52%-0.08%8.34%
1 Month Performance1.88%1.65%7.17%2.83%
1 Year Performance5.22%7.52%24,229.32%159.83%

First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FBT
First Trust NYSE Arca Biotechnology UCITS ETF Class A USD Accumulation
N/AGBX 1,619.50
-1.1%
N/A+5.4%£664.34MN/A-1,472.2720
PRSM
Blue Prism Group
N/AN/AN/AN/A£1.24B£167.30M-23.681,025High Trading Volume
KAPE
Kape Technologies
N/AN/AN/AN/A£1.22B£623.48M1,900.00850Gap Down
KNOS
Kainos Group
1.7186 of 5 stars
GBX 866.50
-1.9%
GBX 1,041.67
+20.2%
+1.6%£1.04B£367.25M3,072.702,953Gap Down
TRST
Trustpilot Group
2.6417 of 5 stars
GBX 228.60
-3.6%
GBX 340.75
+49.1%
+1.0%£931.56M£210.75M16,328.57820Buyback Announcement
Gap Up
LTG
Learning Technologies Group
N/AN/AN/AN/A£792.10M£529.20M16.755,001
ALFA
Alfa Financial Software
1.4465 of 5 stars
GBX 240.50
-2.0%
GBX 276
+14.8%
+16.0%£713.29M£109.90M2,809.58475
GBG
GB Group
2.9567 of 5 stars
GBX 222
-3.1%
GBX 390
+75.7%
-25.3%£547.24M£282.72M6,529.411,183Positive News
IMO
IMImobile
N/AN/AN/AN/A£490.40M£164.04M123.755,300
NCC
NCC Group
2.5098 of 5 stars
GBX 145.40
-0.7%
GBX 175
+20.4%
-14.2%£445.57M£324.40M-1,817.502,200Dividend Cut
CER
Cerillion
N/AGBX 1,415
+1.1%
GBX 2,350
+66.1%
-21.2%£417.44M£42.15M2,941.79321Dividend Increase

Related Companies and Tools


This page (LON:FBT) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners